Cepeda Santiago, Pérez-Nuñez Angel, García-García Sergio, García-Pérez Daniel, Arrese Ignacio, Jiménez-Roldán Luis, García-Galindo Manuel, González Pedro, Velasco-Casares María, Zamora Tomas, Sarabia Rosario
Department of Neurosurgery, University Hospital Río Hortega, 47012 Valladolid, Spain.
Department of Neurosurgery, University Hospital 12 de Octubre, 28041 Madrid, Spain.
Cancers (Basel). 2021 Oct 9;13(20):5047. doi: 10.3390/cancers13205047.
Radiomics, in combination with artificial intelligence, has emerged as a powerful tool for the development of predictive models in neuro-oncology. Our study aims to find an answer to a clinically relevant question: is there a radiomic profile that can identify glioblastoma (GBM) patients with short-term survival after complete tumor resection? A retrospective study of GBM patients who underwent surgery was conducted in two institutions between January 2019 and January 2020, along with cases from public databases. Cases with gross total or near total tumor resection were included. Preoperative structural multiparametric magnetic resonance imaging (mpMRI) sequences were pre-processed, and a total of 15,720 radiomic features were extracted. After feature reduction, machine learning-based classifiers were used to predict early mortality (<6 months). Additionally, a survival analysis was performed using the random survival forest (RSF) algorithm. A total of 203 patients were enrolled in this study. In the classification task, the naive Bayes classifier obtained the best results in the test data set, with an area under the curve (AUC) of 0.769 and classification accuracy of 80%. The RSF model allowed the stratification of patients into low- and high-risk groups. In the test data set, this model obtained values of C-Index = 0.61, IBS = 0.123 and integrated AUC at six months of 0.761. In this study, we developed a reliable predictive model of short-term survival in GBM by applying open-source and user-friendly computational means. These new tools will assist clinicians in adapting our therapeutic approach considering individual patient characteristics.
放射组学与人工智能相结合,已成为神经肿瘤学中开发预测模型的强大工具。我们的研究旨在回答一个临床相关问题:是否存在一种放射组学特征能够识别出肿瘤完全切除后短期生存的胶质母细胞瘤(GBM)患者?2019年1月至2020年1月期间,在两家机构对接受手术的GBM患者进行了回顾性研究,并纳入了来自公共数据库的病例。纳入肿瘤大体全切或近全切的病例。对术前结构多参数磁共振成像(mpMRI)序列进行预处理,共提取15720个放射组学特征。在特征降维后,使用基于机器学习的分类器预测早期死亡率(<6个月)。此外,使用随机生存森林(RSF)算法进行生存分析。本研究共纳入203例患者。在分类任务中,朴素贝叶斯分类器在测试数据集中取得了最佳结果,曲线下面积(AUC)为0.769,分类准确率为80%。RSF模型能够将患者分为低风险和高风险组。在测试数据集中,该模型的C指数 = 0.61,IBS = 0.123,六个月时的综合AUC为0.761。在本研究中,我们通过应用开源且用户友好的计算方法,开发了一种可靠的GBM短期生存预测模型。这些新工具将帮助临床医生根据个体患者特征调整治疗方法。